Top 5 Leading Companies In Real World Evidence Solutions Market Growth Opportunities in Emerging Markets

Real World Evidence Solutions Market

According to the new market research report “Real World Evidence Solutions Market by Component (Dataset, (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) – Global Forecast to 2023” published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Don’t miss out on business opportunities in Real World Evidence Solutions Market. Speak to our analyst and gain crucial industry insights that will help your business Grow:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=76173991

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The global Real World Evidence Solutions Market size is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% 

By component, the data sets segment accounted for the largest share of the real world evidence market in 2017.

On the basis of component, the data sets segment accounted for the largest share of the global real world evidence market. The large share can be attributed to factors such as easy availability of massive amounts of data, increasing dependence of outcome-based studies on real-world data, and rising demand for information by payers and providers regarding drug safety.

By therapeutic area, the oncology segment held the largest market share of the real world evidence market in 2017.

Based on therapeutic area, the oncology segment accounted for the largest share of the real-world evidence market in 2017. The large share of this segment can be attributed to the high number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

Amazon_Audible

Browse and in-depth TOC on “Real World Evidence Solutions Market “
92 — Tables
40 — Figures
157 — Pages
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=76173991

North America dominated the market in 2017.

North America accounted for the largest share of the real world evidence market in 2017, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.

Real World Evidence Solutions Market

 Key Market Players

IQVIA (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), and Optum (US) held the major share of the real world evidence market and will continue to dominate the market between 2018 and 2023.

Other major players operating in this market include International Business Machines Corporation (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

Get More information @ https://bit.ly/3bNWfqJ

Kriti Singh

I’m a Healthcare Corporate Communicator where I help companies to grow and solve their companies growth and research challenges through my creative marketing strategies. Reach out to me in case you have something I can help with.

web hosting